US judge refuses to block Medicare from negotiating drug prices
- A federal judge has ruled that the U.S. Government's Medicare health insurance program can negotiate prices for some prescription drugs starting on October 1, supporting President Joe Biden's initiative to lower drug prices.
- The judge's ruling denied a motion by the Chamber of Commerce, one of the largest lobbying groups, to block the price talks before October 1.
- The Biden administration has emphasized that drug price negotiations do not violate the Constitution, countering arguments from opponents.
Insights by Ground AI
Does this summary seem wrong?
0 Articles
0 Articles
All
Left
Center
Right
Coverage Details
Total News Sources0
Leaning Left3Leaning Right0Center5Last UpdatedBias Distribution63% Center